Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs MDY✓SelectedUSD · MDYGSK vs MDY performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs MDY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+105.2%
MDY return
+165.3%
Excess return
-60.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMDYExcessAlpha
1D+0.5%-0.1%+0.6%+0.6%
7D+1.1%+2.3%-1.1%+0.3%
30D+6.3%+2.0%+4.3%+5.5%
3M+1.8%-5.6%+7.5%+3.9%
6M+1.7%+1.3%+0.4%+0.9%
YTD+6.5%+12.3%-5.8%+1.7%
1Y+9.5%+15.8%-6.3%+3.3%
3Y+65.3%+56.5%+8.8%+36.6%
5Y+43.7%+35.1%+8.6%+24.2%
All+105.2%+165.3%-60.1%+30.0%

Cumulative growth

Daily Returns

Daily percentage return beside MDY.

Daily Out/Under-Performance

Portfolio return minus MDY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MDY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MDY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling